These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 9439900)

  • 1. Isoniazid-related hepatitis.
    Vasudeva R; Woods B
    Dig Dis; 1997; 15(6):357-67. PubMed ID: 9439900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of chronic hepatitis in isoniazid hepatotoxicity during treatment for latent tuberculosis infection.
    Bliven EE; Podewils LJ
    Int J Tuberc Lung Dis; 2009 Sep; 13(9):1054-60. PubMed ID: 19723392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Drug-induced hepatotoxicity caused by anti-tuberculosis drugs in tuberculosis patients complicated with chronic hepatitis].
    Kaneko Y; Nagayama N; Kawabe Y; Shimada M; Suzuki J; Kunogi M; Matsui Y; Kawashima M; Suzuki J; Ariga H; Oshima N; Masuda K; Matsui H; Nagai H; Tamura A; Akagawa S; Toyoda E; Machida K; Kurashima A; Yotsumoto H
    Kekkaku; 2008 Jan; 83(1):13-9. PubMed ID: 18283910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of isoniazid: The good, the bad, and the alternatives.
    Erwin ER; Addison AP; John SF; Olaleye OA; Rosell RC
    Tuberculosis (Edinb); 2019 May; 116S():S66-S70. PubMed ID: 31076322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Baseline abnormal liver function tests are more important than age in the development of isoniazid-induced hepatoxicity for patients receiving preventive therapy for latent tuberculosis infection.
    Gray EL; Goldberg HF
    Intern Med J; 2016 Mar; 46(3):281-7. PubMed ID: 26648478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isoniazid hepatotoxicity associated with treatment of latent tuberculosis infection: a 7-year evaluation from a public health tuberculosis clinic.
    Fountain FF; Tolley E; Chrisman CR; Self TH
    Chest; 2005 Jul; 128(1):116-23. PubMed ID: 16002924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CYP2E1 genotype and isoniazid-induced hepatotoxicity in patients treated for latent tuberculosis.
    Vuilleumier N; Rossier MF; Chiappe A; Degoumois F; Dayer P; Mermillod B; Nicod L; Desmeules J; Hochstrasser D
    Eur J Clin Pharmacol; 2006 Jun; 62(6):423-9. PubMed ID: 16770646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isoniazid-associated hepatitis and antiretroviral drugs during tuberculosis prophylaxis in hiv-infected adults in Botswana.
    Tedla Z; Nyirenda S; Peeler C; Agizew T; Sibanda T; Motsamai O; Vernon A; Wells CD; Samandari T
    Am J Respir Crit Care Med; 2010 Jul; 182(2):278-85. PubMed ID: 20378730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isoniazid-related hepatic failure in children: a survey of liver transplantation centers.
    Wu SS; Chao CS; Vargas JH; Sharp HL; Martín MG; McDiarmid SV; Sinatra FR; Ament ME
    Transplantation; 2007 Jul; 84(2):173-9. PubMed ID: 17667808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of age-related isoniazid hepatotoxicity during treatment of latent tuberculosis infection.
    Aziz H; Shubair M; Debari VA; Ismail M; Khan MA
    Curr Med Res Opin; 2006 Jan; 22(1):217-21. PubMed ID: 16393447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isoniazid-induced acute liver failure during preventive therapy for latent tuberculosis infection.
    Miyazawa S; Matsuoka S; Hamana S; Nagai S; Nakamura H; Nirei K; Moriyama M
    Intern Med; 2015; 54(6):591-5. PubMed ID: 25786447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A review of isoniazid-related hepatotoxicity during chemoprophylaxis.
    Stuart RL; Grayson ML
    Aust N Z J Med; 1999 Jun; 29(3):362-7. PubMed ID: 10868500
    [No Abstract]   [Full Text] [Related]  

  • 13. [Secular increase in the incidence rate of drug-induced hepatitis due to anti-tuberculosis chemotherapy including isoniazid and rifampicin].
    Nagayama N; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H; Mohri M
    Kekkaku; 2003 Apr; 78(4):339-46. PubMed ID: 12739393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unintended consequences: mandatory tuberculin skin testing and severe isoniazid hepatotoxicity.
    Lobato MN; Jereb JA; Starke JR
    Pediatrics; 2008 Jun; 121(6):e1732-3. PubMed ID: 18474531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isoniazid-induced hepatotoxicity in children with latent tuberculosis infection.
    Devrim İ; Devrim F; Bayram N; Aktürk H; Aksay A; Can D; Apa H
    Minerva Pediatr (Torino); 2021 Apr; 73(2):184-187. PubMed ID: 26377643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isoniazid-related fatal hepatitis.
    Salpeter SR
    West J Med; 1996 Nov; 165(5):323. PubMed ID: 8993215
    [No Abstract]   [Full Text] [Related]  

  • 17. Acute liver failure due to antitubercular therapy: Strategy for antitubercular treatment before and after liver transplantation.
    Ichai P; Saliba F; Antoun F; Azoulay D; Sebagh M; Antonini TM; Escaut L; Delvart V; Castaing D; Samuel D
    Liver Transpl; 2010 Oct; 16(10):1136-46. PubMed ID: 20879012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histologically proven isoniazid hepatoxicity in complicated tuberculous salpingitis.
    Semfke A; Wackernagel C; Vier H; Schütz A; Wiechmann V; Gillissen A
    Ther Adv Respir Dis; 2009 Aug; 3(4):159-62. PubMed ID: 19723821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolonged isoniazid prevention in HIV-positive children: hepatotoxicity is not a major problem.
    Loddenkemper R; Diel R
    Int J Tuberc Lung Dis; 2013 Jan; 17(1):1. PubMed ID: 23231996
    [No Abstract]   [Full Text] [Related]  

  • 20. CYP2E1 mediated isoniazid-induced hepatotoxicity in rats.
    Yue J; Peng RX; Yang J; Kong R; Liu J
    Acta Pharmacol Sin; 2004 May; 25(5):699-704. PubMed ID: 15132840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.